In the ovarian cancer cell line SK-OV3, that expresses GnRH-II-R but not GnRH-I-R, native GnRH-II but not GnRH-I agonist triptorelin had anti-proliferative effects [54]. This evidence concerns the gene GNRH2 and ovarian cancer.